-
This looks cool but it is too bad you have to sign up. Would be nice if they offered a download to analyze data locally... -
Making this Sticky, hope no one minds. I have had a lot fun playing with OpenSNP and my data. Any plans on supporting Exome data from 23andMe (or WGS from others)?Leave a comment:
-
New open software tool for 23andme and Decodeme results
New open software tool for 23andme and Decodeme results.
OpenSNP has won Mendeley and the Public Library of Science's Binary Battle that set the challenge of making research more open using those companies' tools, and will receive the grand prize of $10,001. The openSNP tool allows customers of some direct-to-consumer genetic testing companies to upload their raw results, share them, and learn about their variants from the literature. Researchers can also use the shared data. Developer Bastian Greshake, a master's degree student at Goethe University, came up with the idea for openSNP after he was genotyped, the Nature News Blog notes.
The runners up are PaperCritic and rOpenSci.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Leave a comment: